Global Biosimilar Hormones Market Value Expected To Reach $4.10 Billion By 2023 1
Biosimilar Hormones Global Market Report 2020-30: COVID 19 Growth And Change

Teva Pharmaceutical Is One Of The Largest Players In The Biosimilar Hormones Market, According To The Business Research Company’s Biosimilar Hormones Global Market Report 2020-30: COVID 19 Growth And Change

(Companies Covered: Teva Pharmaceutical, Gedeon Richter, Intas Pharmaceuticals, Biocon, Mylan, Sanofi, Sandoz (Novartis), LG Life Sciences, Ferring Pharmaceuticals, GC Pharma.)

The global biosimilar hormones market is expected to decline from $2.05 billion in 2019 to $1.94 billion in 2020 at a compound annual growth rate of -5.18%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $4.10 billion in 2023 at a compound annual growth rate of 28.34%.

Read More On The Global Biosimilar Hormones Market Report At –

https://www.thebusinessresearchcompany.com/report/biosimilar-hormones-global-market-report-2020-30-covid-19-growth-and-change

The biosimilar hormones market consists of sales of biosimilar hormones by entities that engage in manufacturing biosimilar hormones. These hormones are used when patients have a drop in hormones in their bodies or are unbalanced. Only goods and services traded between entities or sold to end consumers are included.

Global Biosimilar Hormones Market Segmentation –
1)By Type : Teriparatide Biosimilars, Follitropin Alfa Biosimilars, Insulin Biosimilars, Somatropin Biosimilars, Others.
2) By Application : Research & biotechnology, Diagnostics, Biocatalysts, Therapeutics, Others.

Global Biosimilar Hormones Market Driver –
Stringent regulations imposed on the approval of hormone biosimilars limits the growth of the biosimilar hormones market. Biosimilars are approved on the same standard of pharmaceutical quality, efficacy, and safety that apply to all biologics approved in the European Union.

Request For A Sample Of The Global Biosimilar Hormones Market Report At –

https://www.thebusinessresearchcompany.com/sample.aspx?id=3432&type=smp

Few Points From The Global Biosimilar Hormones Market TOC
1. Executive Summary
2. Biosimilar Hormones Market Characteristics
3. Biosimilar Hormones Market Size And Growth
3.1. Global Biosimilar Hormones Historic Market, 2015 – 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Biosimilar Hormones Forecast Market, 2019 – 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Biosimilar Hormones Market Segmentation
4.1. Global Biosimilar Hormones Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
4.2. Global Biosimilar Hormones Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5. Biosimilar Hormones Market Regional And Country Analysis
5.1. Global Biosimilar Hormones Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Biosimilar Hormones Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

Media Contact
Company Name: The Business Research Company
Contact Person: Oliver Guirdham
Email: Send Email
Phone: +44 20 7193 0708
Address:
City: London
State: Greater London
Country: United Kingdom
Website: https://www.thebusinessresearchcompany.com/